DCTN1
Death-associated protein kinase 3 (DAPK3), also known as ZIPK (ZIP kinase), is a serine/threonine kinase that plays a crucial role in apoptosis, autophagy, and cell cycle regulation. DAPK3 is a member of the death-associated protein kinase family, which is involved in various cellular processes related to cell death and survival.
Structure[edit | edit source]
DAPK3 is a 454 amino acid protein with a molecular weight of approximately 51 kDa. It contains a kinase domain at the N-terminus, which is responsible for its catalytic activity. The C-terminal region of DAPK3 includes a leucine zipper motif, which is important for its dimerization and interaction with other proteins.
Function[edit | edit source]
DAPK3 is involved in the regulation of several cellular processes:
- Apoptosis: DAPK3 is known to phosphorylate and activate various substrates that promote apoptotic cell death. It is involved in the intrinsic and extrinsic pathways of apoptosis.
- Autophagy: DAPK3 has been implicated in the regulation of autophagy, a process that degrades and recycles cellular components. It modulates autophagic flux by interacting with key autophagy-related proteins.
- Cell Cycle Regulation: DAPK3 plays a role in cell cycle progression, particularly in the G2/M transition. It phosphorylates and regulates proteins involved in mitosis.
Clinical Significance[edit | edit source]
Alterations in DAPK3 expression and activity have been associated with various diseases, including cancer. Overexpression or hyperactivation of DAPK3 has been observed in certain types of cancer, where it may contribute to tumor progression and resistance to apoptosis. Conversely, loss of DAPK3 function can lead to impaired cell death and increased survival of cancer cells.
Research and Therapeutic Potential[edit | edit source]
Due to its role in apoptosis and cell cycle regulation, DAPK3 is a potential target for cancer therapy. Inhibitors of DAPK3 are being investigated for their ability to sensitize cancer cells to apoptosis and enhance the efficacy of existing treatments.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD